Earnings: The real Trump bump
Median per share earnings upgrade of 4% for S&P 500 following tax reform
Analysts’ profits forecasts have edged modestly higher in the first month of the year in continental Europe and the UK, as would be expected during a period of above-consensus global economic data. In the US however, tax reform has added to the cyclical economic strength, pushing median 2018 profits forecasts dramatically higher, up 4% over the past month alone. This represents 2/3rds of our total expected benefit to US earnings from tax reform. Earnings revisions data supports our strategic view of strong momentum carrying over into Q1/Q2 2018. However we also note that economic surprise indices may have peaked in January and combined with forecast rate increases, markets may yet tread water as the year progresses.
Read more...Avacta Group PLC (AVCT): AGM Business Update and Notice of Results
Strong progress with in-house programmes for Affimer Therapeutics and solid progress with partners. Half year revenue, operating losses and cash balances are in line with market forecasts.
Read more...Bushveld Minerals Ld (BMN): Exercise of Convertible Bonds.
Stock down 1.4%
Bushveld Minerals has received notice to exercise £250,000 of convertible bonds at a conversion price of 8.12 pence each.
Read more...EMIS Group PLC (EMIS): Trading Statement.
Stock down 15%
Full year revenue was slightly ahead of the comparative period as the Group continued to benefit from growing recurring revenue, strong market shares and good momentum in its order books and pipelines.
Read more...EMIS Group PLC (EMIS): Review of customer and product support processes
Stock down 15%
The Board of EMIS Group announces that there has been a failure to meet certain service levels and reporting obligations with NHS Digital, relating to the Group’s EMIS Web product for GPs in England. Failure to meet service levels may negatively affect company in the order of upper single digits of millions of pounds. Neither patient safety nor patient data has been put at risk as a result of this issue.
Read more...KEFI Minerals plc (KEFI): Quarterly Operational Update
Stock down 16.3%
Tulu Kapi Gold Project NAV uplift thanks to gold price base-case increase to USD 1,300 and improved economic outputs. Progress being made in Saudi Arabia with promising economic policies being announced by the Kingdom.
Read more...KEFI Minerals plc (KEFI): Funding Plan Update.
Stock down 16.3%
KEFI Minerals reports that Oryx Management Limited and KEFI have mutually agreed to terminate their relationship. The structure for the development of the Company’s Tulu Kapi project will otherwise remain the same with the other existing consortium members performing the various required roles as previously outlined.
Read more...Egdon Resources PLC (EDR): Wressle Forward Plan
Stock down 2.2%
Egdon can advise that it will now prepare and submit a new planning application to North Lincolnshire Council seeking its consent for the Wressle oil field development and prepare and submit a new application to North Lincolnshire Council to extend the current planning consent.
Read more...Oxford Biomedica PLC (OXB): Kymriah receives Priority Review for adult DLBCL
Stock up 3%
Oxford BioMedica is the sole manufacturer of the lentiviral vector that encodes CTL019. The Group signed an agreement with Novartis in July 2017 for the commercial and clinical supply of lentiviral vectors used to generate CTL019 and other undisclosed CAR-T products, for which Oxford BioMedica could potentially receive in excess of $100m from Novartis over the next three years.
Read more...Hurricane Energy PLC (HUR): Listing and Governance Committee Update
Stock down 0.7%
Company adopting best practice procedures of those companies with a Premium Listing. Company searching for a new non-executive Chairman and will appoint further non-executive directors in future.
Read more...